Im confused. Please correct me if I am wrong (I have not followed this for a while now) but AXAL is what they just filed for EMA correct? And isn’t AXAL what received the best ever GOOG results?
If this is true, I thought this was the base to a lot of the comfort to this MB and investors? So many catalysts were tied to this throughout the years (most recently the EMA and the expectation of a partner with it). Now they are announcing they want a partner in 3 months and if they don’t get one, they are going to shelve it? This is what confuses me. If it is not a good product and costing a bunch of money, then yes shelve it. If it has the opportunity to go the distance, but you just want a partner, then don’t announce it like he did. That is either taken as a sign of weakness (we cant afford it and need help) or a threat (if you don’t step up quick, nobody gets it).
If I somehow have any of the technicalities of this messed up with different drugs or trials just let me know and I can take down this post. If all this is true though, how is this at all a good thing for the company? Cutting costs and programs just to start on new ones does not sound smart when you have no money.
If no partner steps up in 3 months, then what happens???
News 
Market Data 
Discover 
AI
